Add-on Azilect leads to greater clinical gains than levodopa alone
A year of treatment with levodopa plus benserazide led to greater clinical improvements among Parkinson’s disease patients who…
Articles by Lindsey Shapiro, PhD
Cognitive tests given virtually can be helpful, but more work needed
Cognition tests given virtually showed results similar to in-person evaluations for Parkinson’s disease patients with no or mild cognitive…
NfL levels may mediate link between dementia, LRRK2 variants
Scientists have discovered that long-term changes in a biomarker of nerve damage, called neurofilament light chain (NfL), could be used…
Reliability seen in using smartwatch to assess patients’ motor function
Motor abilities assessed via multiple sensors on a smartwatch correlated well with motor function as rated by clinicians, and could…
Michael J. Fox receives Catalyst Award for work with MJFF
Michael J. Fox has received the 2023 Elevate Prize Catalyst Award in recognition of his work with the Michael…
FDA updates Nuplazid label to clarify its safe use in Parkinson’s
Note: This story was updated Sept. 20, 2023, to reflect that Acadia is working on Nuplazid’s development as a…
Parkinson’s Foundation launches Reach Further campaign today
The Parkinson’s Foundation has launched a day of giving in an effort to encourage Parkinson’s disease awareness and…
Researchers win Breakthrough Prize for genetics discoveries
The 2024 Breakthrough Prize in Life Sciences has been awarded to three researchers who made groundbreaking discoveries related to the…
Axim develops quick teardrop test that may aid Parkinson’s diagnosis
Axim Biotechnologies has developed an assay to detect toxic clumps of the alpha-synuclein protein, a known biomarker of…
Certain genetic variants linked to sex differences in Parkinson’s risk
Researchers have identified regions of DNA that appear to influence both Parkinson’s disease risk and sex-specific factors, including age…